Synthesis of piperazine-based benzimidazole derivatives as potent urease inhibitors and molecular docking studies

Abstract The development of new bioactive compounds is important for progress in therapeutic research. In the present study, we describe the multistep synthetic approach to develop a library of novel benzimidazole analogs incorporating piperazine rings in order to increase their biological activity....

Full description

Saved in:
Bibliographic Details
Main Authors: Delaram Shahriarynejad, Navid Dastyafteh, Fouzia Naz, Meysam Talebi, Sajedeh Safapoor, Seyedeh Niloufar Ghafouri, Homa Azizian, Maryam Mohammadi-Khanaposhtani, Bagher Larijani, Mehdi Asadi, Massoud Amanlou, Mohammad Mahdavi, Khalid Mohammed Khan
Format: Article
Language:English
Published: Nature Portfolio 2025-08-01
Series:Scientific Reports
Subjects:
Online Access:https://doi.org/10.1038/s41598-025-14723-4
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849333375863619584
author Delaram Shahriarynejad
Navid Dastyafteh
Fouzia Naz
Meysam Talebi
Sajedeh Safapoor
Seyedeh Niloufar Ghafouri
Homa Azizian
Maryam Mohammadi-Khanaposhtani
Bagher Larijani
Mehdi Asadi
Massoud Amanlou
Mohammad Mahdavi
Khalid Mohammed Khan
author_facet Delaram Shahriarynejad
Navid Dastyafteh
Fouzia Naz
Meysam Talebi
Sajedeh Safapoor
Seyedeh Niloufar Ghafouri
Homa Azizian
Maryam Mohammadi-Khanaposhtani
Bagher Larijani
Mehdi Asadi
Massoud Amanlou
Mohammad Mahdavi
Khalid Mohammed Khan
author_sort Delaram Shahriarynejad
collection DOAJ
description Abstract The development of new bioactive compounds is important for progress in therapeutic research. In the present study, we describe the multistep synthetic approach to develop a library of novel benzimidazole analogs incorporating piperazine rings in order to increase their biological activity. In order to synthesize the desired benzimidazole analogs, the synthesis started with the easily accessible precursors between aniline and chloroacetyl chloride. It proceeded via a series of reactions, such as condensation, cyclization, and N-alkylation. TLC optimized each step, and spectroscopic methods such as CHN, IR, EIMS, 1H-NMR, and 13C-NMR were used to characterize the final products. The urease inhibitory activity of the synthesized compounds was evaluated. It was discovered that almost all compounds were quite effective, even more potent (IC50 = 0.15–12.17 µM) than the standard thiourea (IC50 = 23.11 ± 0.21 µM). The structure-activity relationship (SAR) is also established, which displayed that compound 9 L (IC50 = 0.15 ± 0.09 µM) with -NO2 substitutions at meta position play a major role in urease inhibition and figure out as the most potent analog of the library. These results were further verified by molecular docking analysis, which indicated favorable binding energies and interactions of the compounds with the urease active site. This study not only depicts the importance of multistep synthesis but also the structure-based modification approach to produce new pharmacophores for therapeutic applications.
format Article
id doaj-art-eb3a71758fb749d4bf599061e10bb79e
institution Kabale University
issn 2045-2322
language English
publishDate 2025-08-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj-art-eb3a71758fb749d4bf599061e10bb79e2025-08-20T03:45:52ZengNature PortfolioScientific Reports2045-23222025-08-0115111610.1038/s41598-025-14723-4Synthesis of piperazine-based benzimidazole derivatives as potent urease inhibitors and molecular docking studiesDelaram Shahriarynejad0Navid Dastyafteh1Fouzia Naz2Meysam Talebi3Sajedeh Safapoor4Seyedeh Niloufar Ghafouri5Homa Azizian6Maryam Mohammadi-Khanaposhtani7Bagher Larijani8Mehdi Asadi9Massoud Amanlou10Mohammad Mahdavi11Khalid Mohammed Khan12Department of Medicinal Chemistry, Faculty of Pharmacy, Tehran University of Medical SciencesEndocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical SciencesInternational Center for Chemical and Biological Sciences, H. E. J. Research Institute of Chemistry, University of KarachiDepartment of Medicinal Chemistry, Faculty of Pharmacy, Tehran University of Medical SciencesEndocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical SciencesSchool of Chemistry, College of Science, University of TehranDepartment of Medicinal Chemistry, School of Pharmacy, Iran University of Medical SciencesCellular and Molecular Biology Research Center, Health Research Institute, Babol University of Medical SciencesEndocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical SciencesDepartment of Medicinal Chemistry, School of Pharmacy, Iran University of Medical SciencesDepartment of Medicinal Chemistry, Faculty of Pharmacy, Tehran University of Medical SciencesEndocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical SciencesInternational Center for Chemical and Biological Sciences, H. E. J. Research Institute of Chemistry, University of KarachiAbstract The development of new bioactive compounds is important for progress in therapeutic research. In the present study, we describe the multistep synthetic approach to develop a library of novel benzimidazole analogs incorporating piperazine rings in order to increase their biological activity. In order to synthesize the desired benzimidazole analogs, the synthesis started with the easily accessible precursors between aniline and chloroacetyl chloride. It proceeded via a series of reactions, such as condensation, cyclization, and N-alkylation. TLC optimized each step, and spectroscopic methods such as CHN, IR, EIMS, 1H-NMR, and 13C-NMR were used to characterize the final products. The urease inhibitory activity of the synthesized compounds was evaluated. It was discovered that almost all compounds were quite effective, even more potent (IC50 = 0.15–12.17 µM) than the standard thiourea (IC50 = 23.11 ± 0.21 µM). The structure-activity relationship (SAR) is also established, which displayed that compound 9 L (IC50 = 0.15 ± 0.09 µM) with -NO2 substitutions at meta position play a major role in urease inhibition and figure out as the most potent analog of the library. These results were further verified by molecular docking analysis, which indicated favorable binding energies and interactions of the compounds with the urease active site. This study not only depicts the importance of multistep synthesis but also the structure-based modification approach to produce new pharmacophores for therapeutic applications.https://doi.org/10.1038/s41598-025-14723-4BenzimidazolePiperazineUrease inhibitionDocking study
spellingShingle Delaram Shahriarynejad
Navid Dastyafteh
Fouzia Naz
Meysam Talebi
Sajedeh Safapoor
Seyedeh Niloufar Ghafouri
Homa Azizian
Maryam Mohammadi-Khanaposhtani
Bagher Larijani
Mehdi Asadi
Massoud Amanlou
Mohammad Mahdavi
Khalid Mohammed Khan
Synthesis of piperazine-based benzimidazole derivatives as potent urease inhibitors and molecular docking studies
Scientific Reports
Benzimidazole
Piperazine
Urease inhibition
Docking study
title Synthesis of piperazine-based benzimidazole derivatives as potent urease inhibitors and molecular docking studies
title_full Synthesis of piperazine-based benzimidazole derivatives as potent urease inhibitors and molecular docking studies
title_fullStr Synthesis of piperazine-based benzimidazole derivatives as potent urease inhibitors and molecular docking studies
title_full_unstemmed Synthesis of piperazine-based benzimidazole derivatives as potent urease inhibitors and molecular docking studies
title_short Synthesis of piperazine-based benzimidazole derivatives as potent urease inhibitors and molecular docking studies
title_sort synthesis of piperazine based benzimidazole derivatives as potent urease inhibitors and molecular docking studies
topic Benzimidazole
Piperazine
Urease inhibition
Docking study
url https://doi.org/10.1038/s41598-025-14723-4
work_keys_str_mv AT delaramshahriarynejad synthesisofpiperazinebasedbenzimidazolederivativesaspotentureaseinhibitorsandmoleculardockingstudies
AT naviddastyafteh synthesisofpiperazinebasedbenzimidazolederivativesaspotentureaseinhibitorsandmoleculardockingstudies
AT fouzianaz synthesisofpiperazinebasedbenzimidazolederivativesaspotentureaseinhibitorsandmoleculardockingstudies
AT meysamtalebi synthesisofpiperazinebasedbenzimidazolederivativesaspotentureaseinhibitorsandmoleculardockingstudies
AT sajedehsafapoor synthesisofpiperazinebasedbenzimidazolederivativesaspotentureaseinhibitorsandmoleculardockingstudies
AT seyedehniloufarghafouri synthesisofpiperazinebasedbenzimidazolederivativesaspotentureaseinhibitorsandmoleculardockingstudies
AT homaazizian synthesisofpiperazinebasedbenzimidazolederivativesaspotentureaseinhibitorsandmoleculardockingstudies
AT maryammohammadikhanaposhtani synthesisofpiperazinebasedbenzimidazolederivativesaspotentureaseinhibitorsandmoleculardockingstudies
AT bagherlarijani synthesisofpiperazinebasedbenzimidazolederivativesaspotentureaseinhibitorsandmoleculardockingstudies
AT mehdiasadi synthesisofpiperazinebasedbenzimidazolederivativesaspotentureaseinhibitorsandmoleculardockingstudies
AT massoudamanlou synthesisofpiperazinebasedbenzimidazolederivativesaspotentureaseinhibitorsandmoleculardockingstudies
AT mohammadmahdavi synthesisofpiperazinebasedbenzimidazolederivativesaspotentureaseinhibitorsandmoleculardockingstudies
AT khalidmohammedkhan synthesisofpiperazinebasedbenzimidazolederivativesaspotentureaseinhibitorsandmoleculardockingstudies